The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 685K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

45 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The"Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.EBI
Virginia Commonwealth University
Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies.EBI
University of Genoa
Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists.EBI
Roche Innovation Center Basel
Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists.EBI
University of Pisa
Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012.EBI
F. Hoffmann-La Roche
Exploring the structure-activity relationship of the ethylamine portion of 3-iodothyronamine for rat and mouse trace amine-associated receptor 1.EBI
University of California San Francisco
Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class.EBI
Research Triangle Institute
Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773).EBI
F. Hoffmann-La Roche
Amiodarone and its putative metabolites fail to activate wild type hTAAR1.EBI
Rti International
Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites.EBI
University of California San Francisco
Structure-activity correlations for beta-phenethylamines at human trace amine receptor 1.EBI
Rti International
Progress in mechanistically novel treatments for schizophrenia.EBI
Novartis Institutes For Biomedical Research
The Alkaloids from EBI
University of Copenhagen
Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues.EBI
University of California San Francisco
Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia.EBI
Sunovion Pharmaceuticals
Hit-to-Lead Optimization of Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists with a Diphenylmethane-Scaffold: Design, Synthesis, and Biological Study.EBI
University of Pisa
Exploring the determinants of trace amine-associated receptor 1's functional selectivity for the stereoisomers of amphetamine and methamphetamine.EBI
Oregon Health & Science University
Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists.EBI
University of Genoa
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitorsBDB
Dart Neuroscience
Substituted quinazolines for inhibiting kinase activityBDB
Neupharma
5 to 7 membered heterocyclic amides as JAK inhibitorsBDB
Theravance Biopharma R&D Ip
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitorsBDB
Incyte
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamideBDB
Boehringer Ingelheim International
Carboxamide derivatives and use thereofBDB
Purdue Pharma
Benzimidazole-imidazole derivativesBDB
Janssen Ireland
Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.BDB
University of Colorado School of Medicine
Carboxamides as inhibitors of voltage-gated sodium channelsBDB
Amgen
Synthesis and biological evaluation of novel flavanone derivatives as potential antipsychotic agents.BDB
Key Laboratory For Neurodegenerative Diseases of Ministry of Education
Discovery and Characterization of Allosteric WNK Kinase Inhibitors.BDB
Novartis Institutes For Biomedical Research
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninBDB
Albany Molecular Research
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesBDB
Abbvie
2,3-dihydro-1H-indene-2-yl urea derivative and pharmaceutical application of sameBDB
Toray Industries
Pyrimidinyl-piperazines useful as D3/D2 receptor ligandsBDB
Richter Gedeon
Vectorial transport of the peptide CCK-8 by double-transfected MDCKII cells stably expressing the organic anion transporter OATP1B3 (OATP8) and the export pump ABCC2.BDB
German Cancer Research Center
In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.BDB
Parke-Davis Pharmaceutical Research
Affinity of various ligands for GABAA receptors containing alpha 4 beta 3 gamma 2, alpha 4 gamma 2, or alpha 1 beta 3 gamma 2 subunits.BDB
University Clinic For Psychiatry
Defining Cdk5 ligand chemical space with small molecule inhibitors of tau phosphorylation.BDB
Harvard Medical School